2023 annual financial data
Immunome 2023 Operating margin
Immunome 2023 operating margin with verified reported values.
Direct answer
Operating margin was -781.35%.
Operating income was -109,530,000 USD and net income was -106,806,000 USD.
Operating cash flow was -7,568,000 USD.
Get free Immunome email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,018,000 USD
- Operating income
- -109,530,000 USD
- Net income
- -106,806,000 USD
- Operating cash flow
- -7,568,000 USD